Useful Advices
#1 in Business Subscribe Email Print

You are here: Home > Business > Networking > I've Got the Cards, Now What?

Tags

  • advantages
  • events
  • could
  • combination products
  • combination products
  • combination products

  • Links

  • Warning Labels and Warning Signs Don't Warn
  • 9 Tips To Avoid Heartburn During Holiday
  • Liar, Liar
  • Useful Advices - I've Got the Cards, Now What?

    Many business people confuse the idea of quantity and quality when entertaining the thoughts of networking. With a fist full of bu
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    siness cards, they leave most networking events thinking that more is better.

    We've all had the same idea that James Jaccoby had.
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    As a marketing representative for a small printing company, his attitude was that the more business cards he could collect, the be
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tter he was doing his job. His boss even reinforced that idea. At some point James' desk was buried with dusty cards and the refe
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rals he was hoping to get were not coming to him. Jim's thoughts were that he just hadn't met the right number of people yet and h
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    e should just continue to collect more cards.

    With the help of a business coach, James' first step was very painful. The best act
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ion for him to take was to just dump all those cards into the trash. James, at first, couldn't part with those little pieces of in
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ormation, because he had worked so diligently acquiring them. But he realized that those cards had no meaning to him. He really d
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    idn't know any of the people they represented, and certainly those people wouldn't know him. In one quick motion he cleared his de
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    sk.

    "I was feeling pretty uneasy after the big dump, because I didn't know what to do next. Luckily, I was given a few hints. Wh
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    n I went to a networking event, my goal was to talk to only two or three people to find out if I wanted them to be part of my netwo
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    rk circle. Because I actually took the time to talk with these people, I found out a little bit more about them and about what the
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    y do. It helped me to know if I could help them and also if they could assist me in return." James added, "There were some people
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    that I did not ask for their card, because they didn't fit."

    James continued, "When I would get back to my desk later, I would re
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    iew the few business cards, write a follow-up note to each person and then type the contact information into my database. Once tha
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    t was done, I threw the card away. No dust bunnies on my desk! I know this sounds like I was limiting my network, but actually us
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ing this method for the past year, I've gotten more referrals than ever because I am able to stay in touch with these people. In t
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    is instance, less is more for me."

    Networking events have been positioned as the place to meet lots of people. In the past most p
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    eople have interpreted that as meeting as many people as possible. What James has taught us is that by limiting the numbers of car
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ds we acquire, we can free ourselves of business card gridlock. We will be able to move forward toward more business in the future


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.usefuladvices.org.ua/article/31435/usefuladvices-Ive-Got-the-Cards-Now-What.html">I've Got the Cards, Now What?</a>

    BB link (for phorums):
    [url=http://www.usefuladvices.org.ua/article/31435/usefuladvices-Ive-Got-the-Cards-Now-What.html]I've Got the Cards, Now What?[/url]

    Related Articles:

    How To Break Free of the Help Desk

    Medical Billing - GD1 Record

    Are you NICE or do you CARE?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com